Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Influenza

  Free Subscription


30.08.2021

4 Ann Intern Med
4 Antimicrob Agents Chemother
2 Biochem Biophys Res Commun
1 BMJ
5 Cell
14 J Clin Microbiol
2 J Exp Med
1 J Gen Virol
1 J Immunol
2 J Infect
5 J Infect Dis
1 J Virol
2 JAMA
6 Lancet
6 MMWR Morb Mortal Wkly Rep
6 N Engl J Med
3 Pediatrics
2 PLoS Biol
1 PLoS Comput Biol
73 PLoS One
8 Proc Natl Acad Sci U S A
10 Vaccine
1 Virus Res


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Ann Intern Med

  1. AGARWAL A, Lang E
    In adults hospitalized with COVID-19, the 5-variable SOARS score predicted in-hospital mortality.
    Ann Intern Med. 2021 Aug 3. doi: 10.7326/ACPJ202108170.
    PubMed         Abstract available

  2. CHAGLA Z
    In patients with COVID-19, viral shedding time is 17 d and varies in some subgroups.
    Ann Intern Med. 2021 Aug 3. doi: 10.7326/ACPJ202108170.
    PubMed         Abstract available

  3. BLUMENTHAL D, Jacobson GA
    Putting Medicare Spending for COVID-19 Into Perspective.
    Ann Intern Med. 2021 Jun 1. doi: 10.7326/M21-2187.
    PubMed        

  4. ELLIOTT JH, Jeppesen BT
    Rapid and Living Guidance for COVID-19.
    Ann Intern Med. 2021 May 25. doi: 10.7326/M21-2245.
    PubMed        


    Antimicrob Agents Chemother

  5. LI R, Liclican A, Xu Y, Pitts J, et al
    Key Metabolic Enzymes Involved in Remdesivir Activation in Human Lung Cells.
    Antimicrob Agents Chemother. 2021;65:e0060221.
    PubMed         Abstract available

  6. GABORIT B, Dailly E, Vanhove B, Josien R, et al
    Pharmacokinetics and Safety of XAV-19, a Swine Glyco-humanized Polyclonal Anti-SARS-CoV-2 Antibody, for COVID-19-Related Moderate Pneumonia: a Randomized, Double-Blind, Placebo-Controlled, Phase IIa Study.
    Antimicrob Agents Chemother. 2021;65:e0123721.
    PubMed         Abstract available

  7. PASCUA PNQ, Jones JC, Marathe BM, Seiler P, et al
    Baloxavir treatment delays influenza B virus transmission in ferrets and results in limited generation of drug-resistant variants.
    Antimicrob Agents Chemother. 2021 Aug 23:AAC0113721. doi: 10.1128/AAC.01137.
    PubMed         Abstract available

  8. GAMMELTOFT KA, Zhou Y, Duarte Hernandez CR, Galli A, et al
    Hepatitis C Virus Protease Inhibitors Show Differential Efficacy and Interactions with Remdesivir for Treatment of SARS-CoV-2 In Vitro.
    Antimicrob Agents Chemother. 2021;65:e0268020.
    PubMed         Abstract available


    Biochem Biophys Res Commun

  9. BEGUM F, Srivastava AK, Ray U
    Repurposing nonnucleoside antivirals against SARS-CoV2 NSP12 (RNA dependent RNA polymerase): In silico-molecular insight.
    Biochem Biophys Res Commun. 2021;571:26-31.
    PubMed         Abstract available

  10. LONG Y, Song S, Luo F, Han X, et al
    A non-RBM targeted RBD specific antibody neutralizes SARS-CoV-2 inducing S1 shedding.
    Biochem Biophys Res Commun. 2021;571:152-158.
    PubMed         Abstract available


    BMJ

  11. MARCHETTI F, Tamburlini G
    Other good reasons for covid-19 vaccination in pre-adolescent and adolescent populations.
    BMJ. 2021;374:n2052.
    PubMed        


    Cell

  12. KARLSSON EA, Duong V
    The continuing search for the origins of SARS-CoV-2.
    Cell. 2021;184:4373-4374.
    PubMed         Abstract available

  13. KANG L, He G, Sharp AK, Wang X, et al
    A selective sweep in the Spike gene has driven SARS-CoV-2 human adaptation.
    Cell. 2021;184:4392-4400.
    PubMed         Abstract available


  14. What happens next.
    Cell. 2021;184:291-292.
    PubMed        

  15. ZHOU H, Ji J, Chen X, Bi Y, et al
    Identification of novel bat coronaviruses sheds light on the evolutionary origins of SARS-CoV-2 and related viruses.
    Cell. 2021;184:4380-4391.
    PubMed         Abstract available

  16. NATHAN A, Rossin EJ, Kaseke C, Park RJ, et al
    Structure-guided T cell vaccine design for SARS-CoV-2 variants and sarbecoviruses.
    Cell. 2021;184:4401-4413.
    PubMed         Abstract available


    J Clin Microbiol

  17. CALLAHAN C, Lee RA, Lee GR, Zulauf K, et al
    Nasal Swab Performance by Collection Timing, Procedure, and Method of Transport for Patients with SARS-CoV-2.
    J Clin Microbiol. 2021;59:e0056921.
    PubMed         Abstract available

  18. BOERGER AC, Buckwalter S, Fernholz EC, Jannetto PJ, et al
    Evaluation of Self-Collected Midturbinate Nasal Swabs and Saliva for Detection of SARS-CoV-2 RNA.
    J Clin Microbiol. 2021;59:e0084821.
    PubMed         Abstract available

  19. BRADLEY BT, Bryan A, Fink SL, Goecker EA, et al
    Anti-SARS-CoV-2 Antibody Levels Measured by the AdviseDx SARS-CoV-2 Assay Are Concordant with Previously Available Serologic Assays but Are Not Fully Predictive of Sterilizing Immunity.
    J Clin Microbiol. 2021;59:e0098921.
    PubMed         Abstract available

  20. THEEL ES, Johnson PW, Kunze KL, Wu L, et al
    SARS-CoV-2 Serologic Assays Dependent on Dual-Antigen Binding Demonstrate Diverging Kinetics Relative to Other Antibody Detection Methods.
    J Clin Microbiol. 2021;59:e0123121.
    PubMed         Abstract available

  21. L'HUILLIER AG, Lacour M, Sadiku D, Gadiri MA, et al
    Diagnostic Accuracy of SARS-CoV-2 Rapid Antigen Detection Testing in Symptomatic and Asymptomatic Children in the Clinical Setting.
    J Clin Microbiol. 2021;59:e0099121.
    PubMed         Abstract available

  22. AST V, Costina V, Eichner R, Bode A, et al
    Assessing the Quality of Serological Testing in the COVID-19 Pandemic: Results of a European External Quality Assessment (EQA) Scheme for Anti-SARS-CoV-2 Antibody Detection.
    J Clin Microbiol. 2021;59:e0055921.
    PubMed         Abstract available

  23. LIU BM, Beck EM, Fisher MA
    The Brief Case: Ventilator-Associated Corynebacterium accolens Pneumonia in a Patient with Respiratory Failure Due to COVID-19.
    J Clin Microbiol. 2021;59:e0013721.
    PubMed        

  24. LIU BM, Beck EM, Fisher MA
    Closing the Brief Case: Ventilator-Associated Corynebacterium accolens Pneumonia in a Patient with Respiratory Failure Due to COVID-19.
    J Clin Microbiol. 2021;59:e0013821.
    PubMed        

  25. ENGLISH E, Cook LE, Piec I, Dervisevic S, et al
    Performance of the Abbott SARS-CoV-2 IgG II Quantitative Antibody Assay Including the New Variants of Concern, VOC 202012/V1 (United Kingdom) and VOC 202012/V2 (South Africa), and First Steps towards Global Harmonization of COVID-19 Antibody Methods.
    J Clin Microbiol. 2021;59:e0028821.
    PubMed         Abstract available

  26. POLLOCK NR, Berlin D, Smole SC, Madoff LC, et al
    Implementation of SARS-CoV2 Screening in K-12 Schools Using In-School Pooled Molecular Testing and Deconvolution by Rapid Antigen Test.
    J Clin Microbiol. 2021;59:e0112321.
    PubMed         Abstract available

  27. KORENKOV M, Poopalasingam N, Madler M, Vanshylla K, et al
    Evaluation of a Rapid Antigen Test To Detect SARS-CoV-2 Infection and Identify Potentially Infectious Individuals.
    J Clin Microbiol. 2021;59:e0089621.
    PubMed         Abstract available

  28. VAN DEN BELD MJC, Murk JL, Kluytmans J, Koopmans MPG, et al
    Increasing the Efficiency of a National Laboratory Response to COVID-19: a Nationwide Multicenter Evaluation of 47 Commercial SARS-CoV-2 Immunoassays by 41 Laboratories.
    J Clin Microbiol. 2021;59:e0076721.
    PubMed         Abstract available

  29. JEONG S, Lee N, Lee SK, Cho EJ, et al
    Comparing Results of Five SARS-CoV-2 Antibody Assays Before and After the First Dose of ChAdOx1 nCoV-19 Vaccine among Health Care Workers.
    J Clin Microbiol. 2021;59:e0110521.
    PubMed         Abstract available

  30. WHITE PL, Price JS, Backx M
    Evaluation of the Performance of the Associates of Cape Cod STAT Assay for the Diagnosis of Invasive Fungal Disease in Critical-Care Patients with COVID-19.
    J Clin Microbiol. 2021;59:e0086921.
    PubMed         Abstract available


    J Exp Med

  31. LOPEZ J, Mommert M, Mouton W, Pizzorno A, et al
    Early nasal type I IFN immunity against SARS-CoV-2 is compromised in patients with autoantibodies against type I IFNs.
    J Exp Med. 2021;218.
    PubMed         Abstract available

  32. DECKER T
    The early interferon catches the SARS-CoV-2.
    J Exp Med. 2021;218.
    PubMed         Abstract available


    J Gen Virol

  33. RAHMAN F, Libre C, Oleinikov A, Tcherniuk S, et al
    Chloroquine and pyrimethamine inhibit the replication of human respiratory syncytial virus A.
    J Gen Virol. 2021;102.
    PubMed         Abstract available


    J Immunol

  34. PRICE MJ, Scharer CD, Kania AK, Randall TD, et al
    Conserved Epigenetic Programming and Enhanced Heme Metabolism Drive Memory B Cell Reactivation.
    J Immunol. 2021;206:1493-1504.
    PubMed         Abstract available


    J Infect

  35. WEISSMAN YL, Cooper L, Sternbach N, Ashkenazi-Hoffnung L, et al
    Clinical efficacy and safety of high dose trivalent influenza vaccine in adults and immunosuppressed populations -a systematic review and meta-analysis.
    J Infect. 2021 Aug 20. pii: S0163-4453(21)00417.
    PubMed         Abstract available

  36. YOU YS, Kim JS
    Influenza and Anosmia: important prediction factors for severity and death of COVID-19.
    J Infect. 2021 Aug 18. pii: S0163-4453(21)00413.
    PubMed         Abstract available


    J Infect Dis

  37. GIURGEA LT, Cervantes-Medina A, Walters KA, Scherler K, et al
    Sex Differences in Influenza: The Challenge Study Experience.
    J Infect Dis. 2021 Aug 23. pii: 6356350. doi: 10.1093.
    PubMed         Abstract available

  38. BANDOPADHYAY P, D'Rozario R, Lahiri A, Sarif J, et al
    Nature and Dimensions of Systemic Hyperinflammation and its Attenuation by Convalescent Plasma in Severe COVID-19.
    J Infect Dis. 2021;224:565-574.
    PubMed         Abstract available

  39. MAZZITELLI I, Bleichmar L, Luduena MG, Pisarevsky A, et al
    Immunoglobulin G Immune Complexes May Contribute to Neutrophil Activation in the Course of Severe Coronavirus Disease 2019.
    J Infect Dis. 2021;224:575-585.
    PubMed         Abstract available

  40. BARLEV-GROSS M, Weiss S, Paran N, Yahalom-Ronen Y, et al
    Sensitive Immunodetection of Severe Acute Respiratory Syndrome Coronavirus 2 Variants of Concern 501Y.V2 and 501Y.V1.
    J Infect Dis. 2021;224:616-619.
    PubMed         Abstract available

  41. PEART AKINDELE N, Kouo T, Karaba AH, Gordon O, et al
    Distinct Cytokine and Chemokine Dysregulation in Hospitalized Children With Acute Coronavirus Disease 2019 and Multisystem Inflammatory Syndrome With Similar Levels of Nasopharyngeal Severe Acute Respiratory Syndrome Coronavirus 2 Shedding.
    J Infect Dis. 2021;224:606-615.
    PubMed         Abstract available


    J Virol

  42. LIANG W, Zhang Y, Li M, Al-Shaebi F, et al
    Cyclophilin A Inhibits Human Respiratory Syncytial Virus (RSV) Replication by Binding to RSV-N through Its PPIase Activity.
    J Virol. 2021;95:e0056321.
    PubMed         Abstract available


    JAMA

  43. ABBASI J
    Uberantibodies From Recovered COVID-19 Patients Could Spur New Therapeutics and Vaccines.
    JAMA. 2021 Jul 28. pii: 2782673. doi: 10.1001/jama.2021.12915.
    PubMed        

  44. KUEHN BM
    Drug-Resistant Pandemic Influenza Found at Texas Detention Facility.
    JAMA. 2021;326:692.
    PubMed        


    Lancet

  45. MEYER NJ, Gattinoni L, Calfee CS
    Acute respiratory distress syndrome.
    Lancet. 2021 Jul 1. pii: S0140-6736(21)00439.
    PubMed         Abstract available

  46. CAUSEY K, Fullman N, Sorensen RJD, Galles NC, et al
    Estimating global and regional disruptions to routine childhood vaccine coverage during the COVID-19 pandemic in 2020: a modelling study.
    Lancet. 2021 Jul 14. pii: S0140-6736(21)01337.
    PubMed         Abstract available

  47. ROMANIS EC, Parsons JA, Salter I, Hampton T, et al
    Safeguarding and teleconsultation for abortion.
    Lancet. 2021;398:555-558.
    PubMed        

  48. PISANI L, Waweru-Siika W, Sendagire C, Beane A, et al
    Critically ill COVID-19 patients in Africa: it is time for quality registry data.
    Lancet. 2021;398:485-486.
    PubMed        

  49. DOLEZAL L, Rose A, Cooper F
    COVID-19, online shaming, and health-care professionals.
    Lancet. 2021;398:482-483.
    PubMed        

  50. KATSOULARIS I, Fonseca-Rodriguez O, Farrington P, Lindmark K, et al
    Risk of acute myocardial infarction and ischaemic stroke following COVID-19 in Sweden: a self-controlled case series and matched cohort study.
    Lancet. 2021 Jul 29. pii: S0140-6736(21)00896.
    PubMed         Abstract available


    MMWR Morb Mortal Wkly Rep

  51. ROSENBERG ES, Holtgrave DR, Dorabawila V, Conroy M, et al
    New COVID-19 Cases and Hospitalizations Among Adults, by Vaccination Status - New York, May 3-July 25, 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1150-1155.
    PubMed         Abstract available

  52. CZEISLER ME, Board A, Thierry JM, Czeisler CA, et al
    Mental Health and Substance Use Among Adults with Disabilities During the COVID-19 Pandemic - United States, February-March 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1142-1149.
    PubMed         Abstract available

  53. NANDURI S, Pilishvili T, Derado G, Soe MM, et al
    Effectiveness of Pfizer-BioNTech and Moderna Vaccines in Preventing SARS-CoV-2 Infection Among Nursing Home Residents Before and During Widespread Circulation of the SARS-CoV-2 B.1.617.2 (Delta) Variant - National Healthcare Safety Network, March 1-Au
    MMWR Morb Mortal Wkly Rep. 2021;70:1163-1166.
    PubMed         Abstract available

  54. FOWLKES A, Gaglani M, Groover K, Thiese MS, et al
    Effectiveness of COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Frontline Workers Before and During B.1.617.2 (Delta) Variant Predominance - Eight U.S. Locations, December 2020-August 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1167-1169.
    PubMed         Abstract available

  55. TENFORDE MW, Self WH, Naioti EA, Ginde AA, et al
    Sustained Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Associated Hospitalizations Among Adults - United States, March-July 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1156-1162.
    PubMed         Abstract available

  56. GRIFFIN JB, Haddix M, Danza P, Fisher R, et al
    SARS-CoV-2 Infections and Hospitalizations Among Persons Aged >/=16 Years, by Vaccination Status - Los Angeles County, California, May 1-July 25, 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1170-1176.
    PubMed         Abstract available


    N Engl J Med

  57. SCALES D, Gorman J, Jamieson KH
    The Covid-19 Infodemic - Applying the Epidemiologic Model to Counter Misinformation.
    N Engl J Med. 2021 May 12. doi: 10.1056/NEJMp2103798.
    PubMed        

  58. HARRIS RJ, Hall JA, Zaidi A, Andrews NJ, et al
    Effect of Vaccination on Household Transmission of SARS-CoV-2 in England.
    N Engl J Med. 2021 Jun 23. doi: 10.1056/NEJMc2107717.
    PubMed        

  59. BARAS SHREIBATI J
    When Low Tech Wins.
    N Engl J Med. 2021;385:581-583.
    PubMed        

  60. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Monoclonal Antibodies and Booster Shots.
    N Engl J Med. 2021;385:e29.
    PubMed        

  61. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Aspects of Covid-19 Immunity.
    N Engl J Med. 2021;385:e31.
    PubMed        

  62. PHILLIPS S, Williams MA
    Confronting Our Next National Health Disaster - Long-Haul Covid.
    N Engl J Med. 2021;385:577-579.
    PubMed        


    Pediatrics

  63. ROWE SL, Leder K, Perrett KP, Romero N, et al
    Maternal Vaccination and Infant Influenza and Pertussis.
    Pediatrics. 2021 Aug 26. pii: peds.2021-051076. doi: 10.1542/peds.2021-051076.
    PubMed         Abstract available

  64. COWLEY LE, Adesman A
    The Challenge of Identifying Pediatric Abusive Head Trauma During the COVID-19 Pandemic.
    Pediatrics. 2021;148.
    PubMed        

  65. BELL TM, Robbins C, Gosain A
    The Influence of the COVID-19 Pandemic on Pediatric Firearm Injuries.
    Pediatrics. 2021;148.
    PubMed        


    PLoS Biol

  66. HOTEZ PJ
    Mounting antiscience aggression in the United States.
    PLoS Biol. 2021;19:e3001369.
    PubMed         Abstract available

  67. WANG SY, Takahashi T, Pine AB, Damsky WE, et al
    Challenges in interpreting cytokine data in COVID-19 affect patient care and management.
    PLoS Biol. 2021;19:e3001373.
    PubMed         Abstract available


    PLoS Comput Biol

  68. DUTTA R, Gomes SN, Kalise D, Pacchiardi L, et al
    Using mobility data in the design of optimal lockdown strategies for the COVID-19 pandemic.
    PLoS Comput Biol. 2021;17:e1009236.
    PubMed         Abstract available


    PLoS One

  69. KAZEMI SN, Hajikhani B, Didar H, Hosseini SS, et al
    COVID-19 and cause of pregnancy loss during the pandemic: A systematic review.
    PLoS One. 2021;16:e0255994.
    PubMed         Abstract available

  70. BINNIE A, Moura K, Moura C, D'Aragon F, et al
    Psychosocial distress amongst Canadian intensive care unit healthcare workers during the acceleration phase of the COVID-19 pandemic.
    PLoS One. 2021;16:e0254708.
    PubMed         Abstract available

  71. KACHAPILA M, Ademuyiwa AO, Biccard BM, Ghosh DN, et al
    Preliminary model assessing the cost-effectiveness of preoperative chlorhexidine mouthwash at reducing postoperative pneumonia among abdominal surgery patients in South Africa.
    PLoS One. 2021;16:e0254698.
    PubMed         Abstract available

  72. SAJI R, Nishii M, Sakai K, Miyakawa K, et al
    Combining IL-6 and SARS-CoV-2 RNAaemia-based risk stratification for fatal outcomes of COVID-19.
    PLoS One. 2021;16:e0256022.
    PubMed         Abstract available

  73. SHOAIB N, Noureen N, Munir R, Shah FA, et al
    COVID-19 severity: Studying the clinical and demographic risk factors for adverse outcomes.
    PLoS One. 2021;16:e0255999.
    PubMed         Abstract available

  74. POOLE SF, Gronsbell J, Winter D, Nickels S, et al
    A holistic approach for suppression of COVID-19 spread in workplaces and universities.
    PLoS One. 2021;16:e0254798.
    PubMed         Abstract available

  75. MILIC J, Banchelli F, Meschiari M, Franceschini E, et al
    The impact of tocilizumab on respiratory support states transition and clinical outcomes in COVID-19 patients. A Markov model multi-state study.
    PLoS One. 2021;16:e0251378.
    PubMed         Abstract available

  76. CIPRIANO LE, Haddara WMR, Zaric GS, Enns EA, et al
    Impact of university re-opening on total community COVID-19 burden.
    PLoS One. 2021;16:e0255782.
    PubMed         Abstract available

  77. TAMENE A
    What it takes to save lives: An assessment of water, sanitation, and hygiene facilities in temporary COVID-19 isolation and treatment centers of Southern Ethiopia: A mixed-methods evaluation.
    PLoS One. 2021;16:e0256086.
    PubMed         Abstract available

  78. GANDHI S, Sahu M, Govindan R, Nattala P, et al
    Psychological preparedness for pandemic (COVID-19) management: Perceptions of nurses and nursing students in India.
    PLoS One. 2021;16:e0255772.
    PubMed         Abstract available

  79. KARLSSON P, Nakitanda AO, Lofling L, Cesta CE, et al
    Patterns of prescription dispensation and over-the-counter medication sales in Sweden during the COVID-19 pandemic.
    PLoS One. 2021;16:e0253944.
    PubMed         Abstract available

  80. AGARWAL P, Kaushik A, Sarkar S, Rao D, et al
    Global survey-based assessment of lifestyle changes during the COVID-19 pandemic.
    PLoS One. 2021;16:e0255399.
    PubMed         Abstract available

  81. MEHTA K, Zodpey S, Banerjee P, Pocius SL, et al
    Shifting research priorities in maternal and child health in the COVID-19 pandemic era in India: A renewed focus on systems strengthening.
    PLoS One. 2021;16:e0256099.
    PubMed         Abstract available

  82. KAUK J, Kreysa H, Schweinberger SR
    Understanding and countering the spread of conspiracy theories in social networks: Evidence from epidemiological models of Twitter data.
    PLoS One. 2021;16:e0256179.
    PubMed         Abstract available

  83. COSTA KTDS, Morais TNB, Justino DCP, Andrade FB, et al
    Evaluation of the epidemiological behavior of mortality due to COVID-19 in Brazil: A time series study.
    PLoS One. 2021;16:e0256169.
    PubMed         Abstract available

  84. BRINKLEY-RUBINSTEIN L, LeMasters K, Nguyen P, Nowotny K, et al
    The association between intersystem prison transfers and COVID-19 incidence in a state prison system.
    PLoS One. 2021;16:e0256185.
    PubMed         Abstract available

  85. STEPHENSON E, Butt DA, Gronsbell J, Ji C, et al
    Changes in the top 25 reasons for primary care visits during the COVID-19 pandemic in a high-COVID region of Canada.
    PLoS One. 2021;16:e0255992.
    PubMed         Abstract available

  86. CRUZ-ARENAS E, Cabrera-Ruiz E, Laguna-Barcenas S, Colin-Castro CA, et al
    Serological prevalence of SARS-CoV-2 infection and associated factors in healthcare workers in a "non-COVID" hospital in Mexico City.
    PLoS One. 2021;16:e0255916.
    PubMed         Abstract available

  87. CHOI A, Kim HY, Cho A, Noh J, et al
    Efficacy of a four-tier infection response system in the emergency department during the coronavirus disease-2019 outbreak.
    PLoS One. 2021;16:e0256116.
    PubMed         Abstract available

  88. CAPODILUPO ER, Miller DJ
    Changes in health promoting behavior during COVID-19 physical distancing: Utilizing wearable technology to examine trends in sleep, activity, and cardiovascular indicators of health.
    PLoS One. 2021;16:e0256063.
    PubMed         Abstract available

  89. STOCKER A, Demirer I, Gunkel S, Hoffmann J, et al
    Stockpiled personal protective equipment and knowledge of pandemic plans as predictors of perceived pandemic preparedness among German general practitioners.
    PLoS One. 2021;16:e0255986.
    PubMed         Abstract available

  90. PAGE-WILSON G, Arakawa R, Nemeth S, Bell F, et al
    Obesity is independently associated with septic shock, renal complications, and mortality in a multiracial patient cohort hospitalized with COVID-19.
    PLoS One. 2021;16:e0255811.
    PubMed         Abstract available

  91. KAISER U, Vehling-Kaiser U, Schmidt J, Hoffmann A, et al
    The tumor patient in the COVID-19 pandemic-an interview-based study of 30 patients undergoing systemic antiproliferative therapy.
    PLoS One. 2021;16:e0256047.
    PubMed         Abstract available

  92. VAN BLOKLAND IV, Lanting P, Ori APS, Vonk JM, et al
    Using symptom-based case predictions to identify host genetic factors that contribute to COVID-19 susceptibility.
    PLoS One. 2021;16:e0255402.
    PubMed         Abstract available

  93. ZUCKERMAN NS, Bucris E, Erster O, Mandelboim M, et al
    Prolonged detection of complete viral genomes demonstrated by SARS-CoV-2 sequencing of serial respiratory specimens.
    PLoS One. 2021;16:e0255691.
    PubMed         Abstract available

  94. KHALIL A, Dhingra R, Al-Mulki J, Hassoun M, et al
    Questioning the sex-specific differences in the association of smoking on the survival rate of hospitalized COVID-19 patients.
    PLoS One. 2021;16:e0255692.
    PubMed         Abstract available

  95. HAMILTON JR, Stahl EC, Tsuchida CA, Lin-Shiao E, et al
    Robotic RNA extraction for SARS-CoV-2 surveillance using saliva samples.
    PLoS One. 2021;16:e0255690.
    PubMed         Abstract available

  96. GUNSTER C, Busse R, Spoden M, Rombey T, et al
    6-month mortality and readmissions of hospitalized COVID-19 patients: A nationwide cohort study of 8,679 patients in Germany.
    PLoS One. 2021;16:e0255427.
    PubMed         Abstract available

  97. LI Z, Huang X, Hu T, Ning H, et al
    ODT FLOW: Extracting, analyzing, and sharing multi-source multi-scale human mobility.
    PLoS One. 2021;16:e0255259.
    PubMed         Abstract available

  98. VAN DER GOOT WE, Duvivier RJ, Van Yperen NW, de Carvalho-Filho MA, et al
    Psychological distress among frontline workers during the COVID-19 pandemic: A mixed-methods study.
    PLoS One. 2021;16:e0255510.
    PubMed         Abstract available

  99. KILERCIK M, Demirelce O, Serdar MA, Mikailova P, et al
    A new haematocytometric index: Predicting severity and mortality risk value in COVID-19 patients.
    PLoS One. 2021;16:e0254073.
    PubMed         Abstract available

  100. COSMA S, Carosso AR, Cusato J, Borella F, et al
    Preterm birth is not associated with asymptomatic/mild SARS-CoV-2 infection per se: Pre-pregnancy state is what matters.
    PLoS One. 2021;16:e0254875.
    PubMed         Abstract available

  101. MACIEL STR, Rocha MP, Schimmel M
    Urban seismic monitoring in Brasilia, Brazil.
    PLoS One. 2021;16:e0253610.
    PubMed         Abstract available

  102. LITTERA R, Chessa L, Deidda S, Angioni G, et al
    Natural killer-cell immunoglobulin-like receptors trigger differences in immune response to SARS-CoV-2 infection.
    PLoS One. 2021;16:e0255608.
    PubMed         Abstract available

  103. ONISZCZENKO W
    Anxious temperament and cyberchondria as mediated by fear of COVID-19 infection: A cross-sectional study.
    PLoS One. 2021;16:e0255750.
    PubMed         Abstract available

  104. CHUNG PC, Chan TC
    Impact of physical distancing policy on reducing transmission of SARS-CoV-2 globally: Perspective from government's response and residents' compliance.
    PLoS One. 2021;16:e0255873.
    PubMed         Abstract available

  105. ROSEN ML, Rodman AM, Kasparek SW, Mayes M, et al
    Promoting youth mental health during the COVID-19 pandemic: A longitudinal study.
    PLoS One. 2021;16:e0255294.
    PubMed         Abstract available

  106. WISMANS A, Thurik R, Baptista R, Dejardin M, et al
    Psychological characteristics and the mediating role of the 5C Model in explaining students' COVID-19 vaccination intention.
    PLoS One. 2021;16:e0255382.
    PubMed         Abstract available

  107. VLAKE JH, Wesselius S, van Genderen ME, van Bommel J, et al
    Psychological distress and health-related quality of life in patients after hospitalization during the COVID-19 pandemic: A single-center, observational study.
    PLoS One. 2021;16:e0255774.
    PubMed         Abstract available

  108. DALTON JE, Gunzler DD, Jain V, Perzynski AT, et al
    Mechanisms of socioeconomic differences in COVID-19 screening and hospitalizations.
    PLoS One. 2021;16:e0255343.
    PubMed         Abstract available

  109. RATTANAPISIT K, Bulaon CJI, Khorattanakulchai N, Shanmugaraj B, et al
    Plant-produced SARS-CoV-2 receptor binding domain (RBD) variants showed differential binding efficiency with anti-spike specific monoclonal antibodies.
    PLoS One. 2021;16:e0253574.
    PubMed         Abstract available

  110. ARIKAN H, Ozturk S, Tokgoz B, Dursun B, et al
    Characteristics and outcomes of acute kidney injury in hospitalized COVID-19 patients: A multicenter study by the Turkish society of nephrology.
    PLoS One. 2021;16:e0256023.
    PubMed         Abstract available

  111. LISI MP, Scattolin M, Fusaro M, Aglioti SM, et al
    A Bayesian approach to reveal the key role of mask wearing in modulating projected interpersonal distance during the first COVID-19 outbreak.
    PLoS One. 2021;16:e0255598.
    PubMed         Abstract available

  112. SALING LL, Mallal D, Scholer F, Skelton R, et al
    No one is immune to misinformation: An investigation of misinformation sharing by subscribers to a fact-checking newsletter.
    PLoS One. 2021;16:e0255702.
    PubMed         Abstract available

  113. TANDHAVANANT S, Koosakunirand S, Kaewarpai T, Piyaphanee W, et al
    Longitudinal analysis to characterize classes and subclasses of antibody responses to recombinant receptor-binding protein (RBD) of SARS-CoV-2 in COVID-19 patients in Thailand.
    PLoS One. 2021;16:e0255796.
    PubMed         Abstract available

  114. SANCHEZ-GONZALEZ L, Quandelacy TM, Johansson M, Torres-Velasquez B, et al
    Viral etiology and seasonal trends of pediatric acute febrile illness in southern Puerto Rico; a seven-year review.
    PLoS One. 2021;16:e0247481.
    PubMed         Abstract available

  115. MIRANDA-ORTIZ H, Fernandez-Figueroa EA, Ruiz-Garcia EB, Munoz-Rivas A, et al
    Development of an alternative saliva test for diagnosis of SARS-CoV-2 using TRIzol: Adapting to countries with lower incomes looking for a large-scale detection program.
    PLoS One. 2021;16:e0255807.
    PubMed         Abstract available

  116. BAHL R, Eikmeier N, Fraser A, Junge M, et al
    Modeling COVID-19 spread in small colleges.
    PLoS One. 2021;16:e0255654.
    PubMed         Abstract available

  117. BUTT GF, Recchioni A, Moussa G, Hodson J, et al
    The impact of the COVID-19 pandemic on microbial keratitis presentation patterns.
    PLoS One. 2021;16:e0256240.
    PubMed         Abstract available

  118. MOREHOUSE ZP, Samikwa L, Proctor CM, Meleke H, et al
    Validation of a direct-to-PCR COVID-19 detection protocol utilizing mechanical homogenization: A model for reducing resources needed for accurate testing.
    PLoS One. 2021;16:e0256316.
    PubMed         Abstract available

  119. PANZERI A, Bertamini M, Butter S, Levita L, et al
    Factors impacting resilience as a result of exposure to COVID-19: The ecological resilience model.
    PLoS One. 2021;16:e0256041.
    PubMed         Abstract available

  120. JACQUES-AVINO C, Lopez-Jimenez T, Medina-Perucha L, de Bont J, et al
    Social conditions and mental health during COVID-19 lockdown among people who do not identify with the man/woman binomial in Spain.
    PLoS One. 2021;16:e0256261.
    PubMed         Abstract available

  121. HILLYARD M, Sinclair M, Murphy M, Casson K, et al
    The impact of COVID-19 on the physical activity and sedentary behaviour levels of pregnant women with gestational diabetes.
    PLoS One. 2021;16:e0254364.
    PubMed         Abstract available

  122. ALI RN, Rubin H, Sarkar S
    Countering the potential re-emergence of a deadly infectious disease-Information warfare, identifying strategic threats, launching countermeasures.
    PLoS One. 2021;16:e0256014.
    PubMed         Abstract available

  123. GUERETTE J, Blais C, Fiset D
    The absence of fans removes the home advantage associated with penalties called by National Hockey League referees.
    PLoS One. 2021;16:e0256568.
    PubMed         Abstract available

  124. DU X, Shi L, Cao W, Zuo B, et al
    Add-on effect of Chinese herbal medicine in the treatment of mild to moderate COVID-19: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0256429.
    PubMed         Abstract available

  125. PAUL A, Sikdar D, Mahanta J, Ghosh S, et al
    Peoples' understanding, acceptance, and perceived challenges of vaccination against COVID-19: A cross-sectional study in Bangladesh.
    PLoS One. 2021;16:e0256493.
    PubMed         Abstract available

  126. YAN X, Zhu Z
    Quantifying the impact of COVID-19 on e-bike safety in China via multi-output and clustering-based regression models.
    PLoS One. 2021;16:e0256610.
    PubMed         Abstract available

  127. HU W, DeMarcus LS, Sjoberg PA, Robbins AS, et al
    Inactivated influenza vaccine effectiveness among department of defense beneficiaries aged 6 months-17 years, 2016-2017 through 2019-2020 influenza seasons.
    PLoS One. 2021;16:e0256165.
    PubMed         Abstract available

  128. HERNANDEZ-HERNANDEZ AM, Huerta-Quintanilla R
    Managing school interaction networks during the COVID-19 pandemic: Agent-based modeling for evaluating possible scenarios when students go back to classrooms.
    PLoS One. 2021;16:e0256363.
    PubMed         Abstract available

  129. SCHOLZ J, Wetzker W, Licht A, Heintzmann R, et al
    The role of risk communication in public health interventions. An analysis of risk communication for a community quarantine in Germany to curb the SARS-CoV-2 pandemic.
    PLoS One. 2021;16:e0256113.
    PubMed         Abstract available

  130. DIAZ-ESCOBAR J, Ordonez-Guillen NE, Villarreal-Reyes S, Galaviz-Mosqueda A, et al
    Deep-learning based detection of COVID-19 using lung ultrasound imagery.
    PLoS One. 2021;16:e0255886.
    PubMed         Abstract available

  131. MOHAMED NA, Solehan HM, Mohd Rani MD, Ithnin M, et al
    Knowledge, acceptance and perception on COVID-19 vaccine among Malaysians: A web-based survey.
    PLoS One. 2021;16:e0256110.
    PubMed         Abstract available

  132. DUDAS L, Szanto R
    Nudging in the time of coronavirus? Comparing public support for soft and hard preventive measures, highlighting the role of risk perception and experience.
    PLoS One. 2021;16:e0256241.
    PubMed         Abstract available

  133. KAWAMOTO T, Aoki T, Ueda M
    Graph-based open-ended survey on concerns related to COVID-19.
    PLoS One. 2021;16:e0256212.
    PubMed         Abstract available

  134. BECK-FRIIS J, Leach S, Omerovic E, Zeijlon R, et al
    No difference in biomarkers of ischemic heart injury and heart failure in patients with COVID-19 who received treatment with chloroquine phosphate and those who did not.
    PLoS One. 2021;16:e0256035.
    PubMed         Abstract available

  135. DI CROSTA A, Ceccato I, Marchetti D, La Malva P, et al
    Psychological factors and consumer behavior during the COVID-19 pandemic.
    PLoS One. 2021;16:e0256095.
    PubMed         Abstract available

  136. JANSEN GJ, Wiersma M, van Wamel WJB, Wijnberg ID, et al
    Direct detection of SARS-CoV-2 antisense and sense genomic RNA in human saliva by semi-autonomous fluorescence in situ hybridization: A proxy for contagiousness?
    PLoS One. 2021;16:e0256378.
    PubMed         Abstract available

  137. KURZHALS JK, Klee G, Busch H, Hagelstein V, et al
    The impact of the Covid-19 pandemic on quality of life in skin cancer patients.
    PLoS One. 2021;16:e0255501.
    PubMed         Abstract available

  138. MIDWAY SR, Lynch AJ, Peoples BK, Dance M, et al
    COVID-19 influences on US recreational angler behavior.
    PLoS One. 2021;16:e0254652.
    PubMed         Abstract available

  139. ROTHMAN JE, Eidelberg D, Rothman SL, Holford TR, et al
    Analysis of the time course of COVID-19 cases and deaths from countries with extensive testing allows accurate early estimates of the age specific symptomatic CFR values.
    PLoS One. 2021;16:e0253843.
    PubMed         Abstract available

  140. SCHULER L, Calabrese JM, Attinger S
    Data driven high resolution modeling and spatial analyses of the COVID-19 pandemic in Germany.
    PLoS One. 2021;16:e0254660.
    PubMed         Abstract available

  141. BACHMAN CM, Grant BD, Anderson CE, Alonzo LF, et al
    Clinical validation of an open-access SARS-COV-2 antigen detection lateral flow assay, compared to commercially available assays.
    PLoS One. 2021;16:e0256352.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  142. KAUGARS K, Dardick J, de Oliveira AP, Weiss KA, et al
    A recombinant herpes virus expressing influenza hemagglutinin confers protection and induces antibody-dependent cellular cytotoxicity.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available

  143. PAUL BD, Lemle MD, Komaroff AL, Snyder SH, et al
    Redox imbalance links COVID-19 and myalgic encephalomyelitis/chronic fatigue syndrome.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available

  144. AGUILAR E, Roberts NJ, Uluturk I, Kaminski P, et al
    Adaptive staffing can mitigate essential worker disease and absenteeism in an emerging epidemic.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available

  145. BETSCH C, Sprengholz P
    The human factor between airborne pollen concentrations and COVID-19 disease dynamics.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed        

  146. GILLES S, Traidl-Hoffmann C, Damialis A
    Reply to Betsch and Sprengholz: Higher SARS-CoV-2 infection numbers related to more airborne pollen, regardless of testing frequency.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed        

  147. CARTER JG, Orueta Iturbe L, Duprey JHA, Carter IR, et al
    Ultrarapid detection of SARS-CoV-2 RNA using a reverse transcription-free exponential amplification reaction, RTF-EXPAR.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available

  148. SILVA PJS, Sagastizabal C, Nonato LG, Struchiner CJ, et al
    Optimized delay of the second COVID-19 vaccine dose reduces ICU admissions.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available

  149. RAMAN G, Peng JC
    Electricity consumption of Singaporean households reveals proactive community response to COVID-19 progression.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available


    Vaccine

  150. WIEMKEN TL, Salas J, Hoft DF, Jacobs C, et al
    Dementia risk following influenza vaccination in a large veteran cohort running head: Influenza vaccination and dementia.
    Vaccine. 2021 Aug 19. pii: S0264-410X(21)01079.
    PubMed         Abstract available

  151. PENG HK, Dombkowski KJ, Freed GL, Creary SE, et al
    Influenza immunization coverage of children with sickle cell disease.
    Vaccine. 2021 Aug 17. pii: S0264-410X(21)01072.
    PubMed         Abstract available

  152. SUNDARAM M, Nasreen S, Calzavara A, He S, et al
    Background rates of all-cause mortality, hospitalizations, and emergency department visits among nursing home residents in Ontario, Canada to inform COVID-19 vaccine safety assessments.
    Vaccine. 2021 Jul 23. pii: S0264-410X(21)00951.
    PubMed         Abstract available

  153. GEORGIADIS GP, Georgiadis MC
    Optimal planning of the COVID-19 vaccine supply chain.
    Vaccine. 2021 Jul 27. pii: S0264-410X(21)00961.
    PubMed         Abstract available

  154. D'SOUZA MP, Palin AC, Calder T, Golding H, et al
    Mind the gap from research laboratory to clinic: Challenges and opportunities for next-generation assays in human diseases.
    Vaccine. 2021 Aug 5. pii: S0264-410X(21)00964.
    PubMed         Abstract available

  155. SIDDIQUI A, Ahmed A, Tanveer M, Saqlain M, et al
    An overview of procurement, pricing, and uptake of COVID-19 vaccines in Pakistan.
    Vaccine. 2021 Jul 31. pii: S0264-410X(21)00965.
    PubMed        

  156. MAHAJAN A, Kaur J, Sidana C, Shivam S, et al
    Geo-prioritization framework for COVID-19 vaccine allocation in India.
    Vaccine. 2021 Jul 31. pii: S0264-410X(21)00989.
    PubMed         Abstract available

  157. RAHAMIMOV N, Baturov V, Shani A, Ben Zoor I, et al
    Inadequate deltoid muscle penetration and concerns of improper COVID mRNA vaccine administration can be avoided by injection technique modification.
    Vaccine. 2021 Jul 2. pii: S0264-410X(21)00843.
    PubMed         Abstract available

  158. PRIVOR-DUMM LA, Poland GA, Barratt J, Durrheim DN, et al
    A global agenda for older adult immunization in the COVID-19 era: A roadmap for action.
    Vaccine. 2021;39:5240-5250.
    PubMed         Abstract available

  159. FENG J, Li Q
    How to ensure vaccine safety: An evaluation of China's vaccine regulation system.
    Vaccine. 2021 Aug 6. pii: S0264-410X(21)00986.
    PubMed         Abstract available


    Virus Res

  160. KANNIAN P, Jayaraman BG, Alamelu S, Lavanya C, et al
    Implications in the quantification of SARS-CoV2 copies in concurrent nasopharyngeal swabs, whole mouth fluid and respiratory droplets.
    Virus Res. 2021;303:198442.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Influenza is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: